← Back to Search

Nonsteroidal Anti-inflammatory Drug

Ibuprofen for Elevated PSA Levels

Phase 4
Recruiting
Led By Scott Eggener, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male patients age between 18-80 years old with a screening PSA > 3 ng/ml being considered for additional diagnostic testing (e.g., MRI, biopsy)
No clinical symptoms concerning acute urinary tract infection (e.g. dysuria, malodorous urine, positive urine culture)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks
Awards & highlights
Drug Has Already Been Approved
No Placebo-Only Group
Pivotal Trial

Study Summary

This trial will test whether ibuprofen can lower PSA levels in men with slightly elevated levels, which may help prevent prostate cancer.

Who is the study for?
This trial is for men aged 18-80 with a PSA level over 3 ng/ml who are being considered for further prostate tests but have no symptoms of urinary infection or known prostate cancer. They must not be on blood thinners, anti-inflammatory drugs, have severe liver/kidney disease, history of GI bleeding, urethral catheter use recently, or NSAID allergies.Check my eligibility
What is being tested?
The study is testing the effects of taking ibuprofen (400 mg) on men with elevated PSA levels to see if it impacts their need for additional diagnostic procedures like MRI or biopsy.See study design
What are the potential side effects?
Possible side effects include digestive issues such as stomach pain and heartburn, increased risk of gastrointestinal bleeding especially in those with a history of ulcers or bleeds, and potential kidney problems.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a man aged 18-80 with a PSA level over 3 ng/ml and might need more tests.
Select...
I don't have symptoms of a urinary tract infection.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change of serum PSA compared with baseline
Secondary outcome measures
Change of International Prostate Symptom Score (IPSS) compared with baseline

Awards & Highlights

Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: IbuprofenExperimental Treatment1 Intervention
Participants receive Ibuprofen 400 mg tablet orally every 8 hours for 10 days
Group II: ControlActive Control1 Intervention
Participants receive no NSAIDs
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ibuprofen 400 mg
2021
Completed Phase 4
~1730

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
989 Previous Clinical Trials
816,053 Total Patients Enrolled
Scott Eggener, MDPrincipal InvestigatorUniversity of Chicago
4 Previous Clinical Trials
512 Total Patients Enrolled

Media Library

Ibuprofen (Nonsteroidal Anti-inflammatory Drug) Clinical Trial Eligibility Overview. Trial Name: NCT05512754 — Phase 4
Prostate Specific Antigen Test Research Study Groups: Ibuprofen, Control
Prostate Specific Antigen Test Clinical Trial 2023: Ibuprofen Highlights & Side Effects. Trial Name: NCT05512754 — Phase 4
Ibuprofen (Nonsteroidal Anti-inflammatory Drug) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05512754 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this study limit its participants to those 35 years or younger?

"The age limit to participate in this trial is 80 years young."

Answered by AI

Do I meet the qualifications to take part in this research study?

"To be applicable for this study, male patients must be between 18 and 80 years old, have a PSA above 3 ng/ml, be considering additional diagnostic testing, have a normal digital rectal examination, and have no clinical symptoms concerning acute urinary tract infection. 200 participants are needed in total."

Answered by AI

Is it dangerous to take Ibuprofen 400 mg for a long period of time?

"Ibuprofen 400 mg is approved and, thus, considered safe."

Answered by AI

Are there any unfilled vacancies for participants in this experiment?

"Yes, you're right. The listing on clinicaltrials.gov shows that this trial is open for recruitment. It was first posted on August 1st, 2020 and was last updated on October 10th, 2020. They are looking for 200 people to participate at 1 site."

Answered by AI
~43 spots leftby Jul 2024